chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shots administered at 2:30 p.m. appointment which include TD and Meningococcal. Patient felt fine going into appointment for vacines. Later at 9:00p.m. patient feels like arms are spaghetti feeling he had no feeling in arms and headache only in frontal part of skull from forehead to top of head only in center of head. Also fast heartbeat and clammy to the touch. Will watch all night to be sure nothing happens and will go to hospital if symptoms continue.
Extreme fatigue (3 days  in bed), headache, backache, diarrhea, joint pain (left ankle). Out of bed on fourth day but still fatigued, with pronounced limp from left ankle pain, also some diarrhea
Itching throughout the whole body; Feels like sunburn throughout his body; little bumps on his face; Rash on his face; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching throughout the whole body), RASH ERYTHEMATOUS (Feels like sunburn throughout his body), MASS (little bumps on his face) and RASH (Rash on his face) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SERTRALINE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching throughout the whole body), RASH ERYTHEMATOUS (Feels like sunburn throughout his body), MASS (little bumps on his face) and RASH (Rash on his face). At the time of the report, PRURITUS (Itching throughout the whole body), RASH ERYTHEMATOUS (Feels like sunburn throughout his body), MASS (little bumps on his face) and RASH (Rash on his face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
a bruise" next to her left elbow; reported "a bruise"next to her left elbow and she described that"looks like a blood clot"; left arm is hot; swelling between neck and shoulder (left side); "huge left arm"; pain between her neck and shoulder (left side); further down from the injection site "huge welt"; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (left arm is hot), SWELLING (swelling between neck and shoulder (left side)), CONTUSION (a bruise" next to her left elbow), CONTUSION (reported "a bruise"next to her left elbow and she described that"looks like a blood clot") and URTICARIA (further down from the injection site "huge welt") in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced URTICARIA (further down from the injection site "huge welt"). On 05-May-2021, the patient experienced FEELING HOT (left arm is hot) and VACCINATION SITE SWELLING ("huge left arm"). 05-May-2021, the patient experienced SWELLING (swelling between neck and shoulder (left side)) and ARTHRALGIA (pain between her neck and shoulder (left side)). On 06-May-2021, the patient experienced CONTUSION (a bruise" next to her left elbow) and CONTUSION (reported "a bruise"next to her left elbow and she described that"looks like a blood clot"). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site swelling and Swelling, at a dose of 500 milligram. At the time of the report, FEELING HOT (left arm is hot), SWELLING (swelling between neck and shoulder (left side)), CONTUSION (a bruise" next to her left elbow), CONTUSION (reported "a bruise"next to her left elbow and she described that"looks like a blood clot"), URTICARIA (further down from the injection site "huge welt"), VACCINATION SITE SWELLING ("huge left arm") and ARTHRALGIA (pain between her neck and shoulder (left side)) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-110472 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-110472:Case for daughter
Heart palpitations, faster and fluttering; Heart palpitations; dose 1 on 01Apr2021/dose 2 on 07Sep2021; left hand felt somewhat numb; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 07Sep2021 at 08:45 am (Lot Number: EW0177, unknown expiration) as dose 2, single at the age of 62 years old for COVID-19 immunisation. Medical history included penicillin allergy and sulfa allergy. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EP6955) on 01Apr2021 at 10:00 am in the left arm at the age of 61 years old for COVID-19 immunization and experienced heart palpitations, faster and fluttering/pounding heart rate (1st vaccine heart related reaction lasted 4 weeks). No history of COVID prior to vaccination and has not been tested for COVID post vaccination. No other vaccine in four weeks. On 07Sep2021 at 17:30, the patient experienced heart palpitations, faster and fluttering after the second vaccine. Events still present this morning. Pounding heart rate is not as bad as first vaccine but concerning. While waiting at the hospital after receiving the vaccine on 07Sep2021, the patient's left hand felt somewhat numb, but subsided. The patient did not receive treatment for the events. The patient recovered from left hand numb on 07Sep2021, while the patient has not yet recovered from the remaining events.  No follow-up attempts are possible; information about batch number was already obtained.
fatigue; chills; sore muscles; nausea; Swollen and sensitive gums; achy feeling; Swollen and sensitive gums; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 09:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included non-celiac gluten sensitivity and heart palpitations (SVT). The patient did not receive any concomitant medications. The patient did not have any allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Mar2021 at 09:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 12:00, the patient experienced swollen and sensitive gums, nausea, fatigue, achy feeling, sore muscles, chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen and sensitive gums, nausea, fatigue, achy feeling, sore muscles, chills was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Joint paiin; injection site pain; This is a spontaneous report received from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on an unknown date and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EK5730) via an unspecified route of administration in the left arm on an unknown date both as a single dose, for COVID-19 immunisation. Medical history included Sulpha drugs allergies and concomitant medication was not reported.. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced joint pain and injection site pain. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of joint pain and vaccination site pain were unknown at the time of this report.   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: updated Anatomical Location for dose 1 and dose 2 and updated narrative.
Patient works and goes to college. States recieved a letter from the school stating he need an MMR for them, he presented to the Health Unit requesting an mmr. States that 2-3 days later he became ill with fever,weakness extreme fatigue he was admitted to hospital for 3-4 days. He then went to his cancer doctor who admitted him to another hospital for 4 days. He states "My immune system was messed up." He is back to work but states his blood work is still messed up. 10/24/08-records received for DOS 8/26-8/28/08-DC DX: Chronic lymphocytic leukemia. Hypogammaglobulinemia. Exposure to measles, mumps and rubella vaccine. This vaccine is contraindicated in hypogammaglobulinemic states. Nausea.  Presented with C/O malaise, generalized achiness and not feeling quite right, some chest tightness and dry cough.
Pain day of injection left arm per mom, redness 2 days later, went urgent care give antibiotic, seen my office 3d later, arm still little warm, no redness/swelling.
Child was given a Varicella vaccine on 03/08/06 Was given a 2nd Varicella vaccine by accident on  04/12/06.  Patient was fine. Notified CDC. They indicated no concern. The 2nd vaccine was only an exposure to Varicella and the 1st was to give her immunity.
Received COVID-19 vaccination late Dec2020 or early Jan2021/contracted COVID-19 infection in a foreign country; Received COVID-19 vaccination late Dec2020 or early Jan2021/contracted COVID-19 infection in a foreign country; This is a spontaneous report from a contactable physician. A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not available to reporter), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was unknown if other vaccine received in four weeks or if covid prior vaccination. It was reported that physician received COVID-19 vaccination late Dec2020 or early Jan2021. Traveled to another country (where he was originally from) sometime in early 2021, contracted COVID-19 infection in Apr2021, and unfortunately died sometime in Apr2021 while still in a foreign country. He had no known comorbidities. The patient underwent lab test which included covid tested post vaccination with unknown results on an unspecified date. It was unknown if any treatment received. The outcome of the events was fatal. The patient died in Apr2021. It was unknown if an autopsy was performed.  The events Drug ineffective and COVID-19 occurred in a country different from that of the reporter. This may be a duplicate report if another reporter from the country where the events occurred has submitted the same information to his/her local agency.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to agency, as appropriate.; Reported Cause(s) of Death: Received COVID-19 vaccination late Dec2020 or early Jan2021/contracted COVID-19 infection in a foreign country; Received COVID-19 vaccination late Dec2020 or early Jan2021/contracted COVID-19 infection in a foreign country.
mild arm pain 4 hours; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 77 year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in deltoid left, administration date 11Feb2021 (Batch/Lot number: unknown) as Dose 2, Single for covid-19 immunisation. Relevant medical history included: "Increased Blood Pressure" (unspecified if ongoing); "CAVD (Coronary artery disease)" (unspecified if ongoing); "Hyperlipidemia/ Lipid control" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure increased, start date: 2015 (ongoing); METOPROLOL taken for blood pressure increased, start date: 2015 (ongoing); ASPIRIN [ACETYLSALICYLIC ACID] taken for coronary artery disease, start date: 2015 (ongoing); LIPITOR [ATORVASTATIN] taken for hyperlipidaemia, start date: 2015 (ongoing); CLARITINE taken for seasonal allergy, start date: 2016 (ongoing). Vaccination history included: Bnt162b2 (first dose, right deltoid muscle, Intramuscular, Time: 02:00 PM), administration date: 21Jan2021, for COVID-19 Immunisation, reaction(s): "Pain/pain in the right arm/most severe pain patient had ever had; patient would say 30 times worse than any fly shot for example"; Bnt162b2 (first dose, right deltoid muscle, Intramuscular, Time: 02:00 PM), administration date: 21Jan2021, for covid-19 immunisation, reaction(s): "Pain into shoulder area, deltoid muscle nearly totally paralyzed", "pain down arm to elbow", "could not sleep".  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "mild arm pain 4 hours". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: the patient (reporter/ physician) provide information regarding the product adverse events with the use of the product. The patient also consider the Pfizer product had a causal effect to the adverse event. Patient prior vaccination was none. The patient noted: "I am not dead".  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021143343 same patient/drug, different events/dose number
Received dose #2. Around 11pm awoke with extreme pain with body aches, pains, skin sensitivity, muscle soreness and feverish (sweat with cold chills), also experiencing severe headache and stiff neck.
Pfizer-BioNTech COVID-19 Vaccine EUA;  Generalized Itchy rash with hives all over body not relieved by benadryl, zyrtec, claritin and pepcid.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 03Sep2021 (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Had soreness and body ache"; CONFUSIONAL STATE (non-serious), DIZZINESS (non-serious), NAUSEA (non-serious) all with onset 07Sep2021, outcome "unknown" and all described as "I was walking around and then felt like confused, dizzy and something like nausea". Additional information: Patient got first dose of the vaccine on Friday afternoon. Patient had the soreness and like body ache and that kind of stuff, today while returning to work was kind of walking around and then begins feeling, kind of confused and dizzy also something like nausea. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
SWELLING, HARD AND SORE AT INJECTION SITE. DIARRHEA, VOMITING, SEVERE WHOLE BODY MUSCLE PAIN. WAS BEDRIDDEN FOR 4 DAYS AND TOOK A TOTAL OF 10 DAYS TO RECOVER. PATIENT STATED THE ADVERSE EVENTS STARTED WITHIN 1/2 TO 1 HOUR AFTER THE VACCINE. TOOK ALEVE FOR THE MUSCLE PAIN AND DID NOT SEEK MEDICAL HELP.
Delayed reaction.  Large red, hard, swollen area at the injection site.  Hot to the touch.  Individual reports that it is very itchy.
My daughter has been coughing; am an exclusively breastfeeding mother; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Nov2021 13:00 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "known_allergies: Sulfa" (unspecified if ongoing); "if_covid_prior_vaccination: Yes" (unspecified if ongoing), notes: if_covid_prior_vaccination: Yes. The patient's concomitant medications were not reported. The following information was reported: COUGH (non-serious) with onset 19Nov2021 13:30, outcome "recovering", described as "My daughter has been coughing"; EXPOSURE VIA BREAST MILK (non-serious) with onset 19Nov2021 13:30, outcome "recovering", described as "am an exclusively breastfeeding mother". Therapeutic measures were not taken as a result of cough, exposure via breast milk.  Additional information: Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient had received Prenatal, vitamin D, Vitamin B, Zinc, superfoods within 2 weeks of vaccination. Patient had received within 2 weeks of vaccination. Patient had not been covid tested post vaccination. Patient had not received any treatment ae. Patient had diagnosed with COVID-19 Prior to vaccination. Patient had not been tested for COVID-19 Since the vaccination. Patient had Military Facility where the most recent COVID-19 vaccine was administered. Dizziness, Pain in the left arm, shoulder blade and collar bone, Occasional pin like feeling when breathing, Itching on the left arm, Pain in my left ovaries, Little bit of a sore throat, Felt like my throat was swollen a bit with some cotton mouth, My daughter has been coughing (I am an exclusively breastfeeding mother).   Follow-up attempts are completed; information about lot/batch number cannot be obtained. No further information is expected.
Mother called on 5/22/06 reporting fevers 6-4 days after shot given on 5/15/06. How has fine red rash to chest, back, neck. Otherwise doing well and fevers have now broken.
Patient presented to the site in order to get vaccinated with her second dose of Moderna.  The patient was accompanied with her Father.  Administrators at the site identified that the patient was under the age of 18 however had already been vaccinated with the first dose on 02APR2021 with Moderna.  It was brought to the attention of the site upper staff and this writer.  I discussed the situation with the patient and the patient's father who reported a preference to have a second dose and for it to be Pfizer.  This writer spoke with colleague.  This writer informed the patient and father that we would not give a second dose of Pfizer, however would give the second dose of Moderna with the understanding that this would be "off label." This writer also gave the patient and father the option to not be vaccinated today and to be seen by their pediatrician.  Patient and father is requesting Moderna vaccine.  This writer discussed risks and benefits as well as options.  Patient was vaccinated with Moderna.  Patient and father report that the patient did not have an appointment for the first visit and that she was the father, "plus one."  The patient presented a passport during that visit.  The father reports that "this was the first day under 18y/o individuals were authorized," and that he was unable to schedule her an appointment until greater than one week from 02APR2021 which is why he brought her as a "plus one."
pt exp a serum sickness-like rxn 36hrs following vax;no further details were provided;
Headache, Arthralgia, FATIGUE, CHILLS, PAIN/SWELLING INJ SITE, LOCAL LYMPH NODE TENDER/SWELLING Narrative:  Other Relevant History:
Hospitalized 5/13/22-5/17/22 chest pain, cough, palpation's, dyspnea, hypoxia, tachycardia, nausea, sepsis, cholecystitis,
The nurse reports she received the Pfizer COVID-19 vaccines, and she had reactions including breast lymph node; This is a spontaneous report received from non-contactable reporter(s) (Nurse). The reporter is the patient. Other Case identifier(s): MOD22-012425 (Moderna).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BREAST MASS (non-serious), outcome "unknown", described as "The nurse reports she received the Pfizer COVID-19 vaccines, and she had reactions including breast lymph node".  Additional information: Description of A nurse on behalf of her mother who received the Modema Covid-19 booster dose in Event or Problem Jan2022. Patient reports that her mom has been experiencing an itchy rash, and the itchiness still has not gone away. Reporter reports big purple rash, with urticaria.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.